Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 15Uterine Cervical Neoplasms 12Carcinoma, Ovarian Epithelial 10Fallopian Tube Neoplasms 8Endometrial Neoplasms 7Peritoneal Neoplasms 4Colorectal Neoplasms 3Vulvar Neoplasms 2Vaginal Neoplasms 2Recurrence 2Uterine Neoplasms 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Shoulder Impingement Syndrome 1Sarcoma 1Pregnancy Complications 1Postoperative Complications 1Pelvic Neoplasms 1Patient Satisfaction 1Pain, Postoperative 1Ovarian Germ Cell Cancer 1Ovarian Cysts 1Neoplasms 1Neoplasm Metastasis 1Myofibroma 1Mesothelioma, Malignant 1Mesothelioma 1Leiomyoma 1Infertility, Female 1

Interventions

camrelizumab 1Surgical Procedures, Operative 1Paclitaxel 1ON123300 1Letrozole 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrioid Endometrial Cancer × Surgical Procedures, Operative × Gynecologic × Clear all
NCT06561308 2025-12-01

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Women's Hospital School Of Medicine Zhejiang University

Phase 2 Recruiting
39 enrolled
Gynecologic

Endometrioid Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡